Mike Botta
Contributing Editor

As a Contributing Editor for Advantage Business Media's manufacturing group, Mike Botta contributes across all of the manufacturing brands, creating content and spearheading a variety of projects. Mike has held senior publishing positions at the Fairchild Publications and Chilton Publishing units of Capital Cities/ABC, Reed Business Information, Advantage Business Media (2006-2007), and Thomas Publishing. He served as Editor-in-Chief of the American Metal Market daily business newspaper for several years, eventually moving up to the position of Publisher. He joined Reed in Rockaway, NJ in 2003 as Editorial Director of the manufacturing publications and was later named Publishing Director of the manufacturing group. When Advantage acquired the Rockaway properties in 2006, Mike was named Director of Content. Most recently he served as Editorial Director of TCC Media’s Industrial Equipment News and handled a variety of special projects for other publications, including production of Show Dailies and in-depth interviews with business leaders. Mike and his family relocated from Northern New Jersey to the suburbs of Phoenix, AZ in 2009.

That a tech giant like Amazon could cause a major shift in the pharma, medical, and biotech sector demonstrates how e-commerce, technology, and analytics have...
Contributing Editor
|
2.13.2018
6:39am
The FDA has issued a series of updates regarding drugs that are currently in shortage or have been discontinued.
Contributing Editor
|
2.12.2018
7:05am
A new validation tool introduced recently by MasterControl Inc. can cut software validation time from months to days or hours, according to the company.
Contributing Editor
|
1.31.2018
1:10pm
Epiduo Gel is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. Estrace Cream is indicated in the treatment of...
Contributing Editor
|
1.26.2018
5:15am
The contract development and manufacturing organization (CDMO) now works with a number of clients in Japan, including two big pharma companies, providing...
Contributing Editor
|
1.24.2018
5:30am
Advertisement
The company, headquartered in Salt Lake City, has established a team with decades of experience in nutraceutical and supplement manufacturing, formulation,...
Contributing Editor
|
1.24.2018
5:00am
The FDA issued updates regarding several drugs that are currently in shortage or have been discontinued.
Contributing Editor
|
1.22.2018
8:50am
The provider of tech solutions in the field of thermal insulation and cold chain logistics says it invested "several million dollars" in its U.S....
Contributing Editor
|
1.22.2018
5:52am
The U.S. Patent & Trademark Office concluded that the sole unexpired Zytiga claim was "unpatentable." Johnson & Johnson said the company is...
Contributing Editor
|
1.18.2018
9:06am
The awards were established to recognize companies that showcase creative technologies and/or new strategies and services that have significantly improved...
Contributing Editor
|
1.17.2018
6:52pm
The FDA issued updates regarding several drugs that are currently in shortage or have been discontinued.
Contributing Editor
|
1.11.2018
8:00am
The company said it added 75 new pharmaceutical and contract manufacturing (CMO) customers in Q4 of 2017, with 50 new manufacturing customers added in the...
Contributing Editor
|
1.9.2018
5:34am
The company is launching a nutritional supplement line to restore and boost natural energy. "Broadening our portfolio into the health and wellness...
Contributing Editor
|
1.9.2018
4:55am
Advertisement
The voluntary but reluctant move follows a strong recommendation from the Food and Drug Administration that the osteoarthritis product may cause drug-induced...
Contributing Editor
|
1.4.2018
9:42am
FDA Commissioner Scott Gottlieb, M.D. outlined new steps that facilitate efficient generic drug review to enhance competition, promote access, and lower drug...
Contributing Editor
|
1.4.2018
7:30am
Canada's Pivot Pharmaceuticals has entered a 45-day 'standstill agreement' to explore a potential partnership for commercialization of health-...
Contributing Editor
|
12.28.2017
4:55am
Mallinckrodt will initiate a cash tender offer for $18.00 per share. The transaction includes development and commercial assets, including Amitiza (...
Contributing Editor
|
12.26.2017
9:38am
Merck and Pfizer will share potential revenues and certain costs on a 60/40 percent basis, respectively, and Pfizer may be entitled to additional milestone...
Contributing Editor
|
12.26.2017
8:23am
A nutritional product manufacturer in Arkansas reports that a newly installed cotton inserter automatically separates cotton from a roll without requiring...
Contributing Editor
|
12.22.2017
4:30am
The FDA issued additional updates regarding drugs that are currently in shortage. The announcement adds to the list released on Wednesday.
Contributing Editor
|
12.14.2017
3:00pm
The FDA issued updates regarding drugs that are currently in shortage or have been discontinued.
Contributing Editor
|
12.13.2017
10:23am
Advertisement
The primary objective of the study is to demonstrate safety and tolerability of islet transplantation into the Cell Pouch and the secondary objective is to...
Contributing Editor
|
12.13.2017
7:00am
Pegfilgrastim, a long-acting version of the oncology-supportive care medicine filgrastim, demonstrated several matching profiles for the Sandoz biosimilar...
Contributing Editor
|
12.11.2017
6:30am
Genomic Health's research collaboration with Janssen will evaluate a genomic prostate score test for potential drug development, while collaboration with...
Contributing Editor
|
12.6.2017
8:58am
Idorsia will receive a milestone payment of $230 million from Janssen Biotech. The two companies will share equally the costs for Phase 3 development of...
Contributing Editor
|
12.5.2017
8:30am
Viagra Connect becomes the first medicine for erectile dysfunction to be reclassified from Prescription Only Medicine (POM) to Pharmacy (P) status in the U.K....
Contributing Editor
|
12.1.2017
9:00am
Avery Products Corporation, a division of CCL Industries, has filed a lawsuit against sellers of alleged counterfeit labels in the United States in an effort...
Contributing Editor
|
12.1.2017
4:55am
The FDA has placed Idera Pharmaceutical's lead development candidate IMO-2125 on the fast track for the treatment of anti-PD-1 refractory metastatic...
Contributing Editor
|
11.30.2017
9:11am
PLEO-CMT is a pivotal, multi-center, randomized, double blind, placebo-controlled Phase III study that was initiated in December 2015 and has enrolled 323...
Contributing Editor
|
11.30.2017
7:48am
The manufacturing of Russian biosimilars of rituximab and bevacizumab indicated for the treatment of cancer, approved in the first half of October 2017, will...
Contributing Editor
|
11.29.2017
9:40am
UPDATED 12/1/17 ... The FDA issued updates regarding drugs that are currently in shortage or have been discontinued.
Contributing Editor
|
11.29.2017
8:58am
Teva Pharmaceutical Industries Ltd. announced a new leadership structure Monday, days after news reports in Israel cited unnamed sources as saying the company...
Contributing Editor
|
11.27.2017
12:54pm
Mitsui Chemicals in collaboration with Bilcare introduces Chemipearl XSP in India. It's a new high-performance heat seal coating using water based...
Contributing Editor
|
11.21.2017
7:30am
The Leukemia & Lymphoma Society has invested more than $1 billion in cancer research in its nearly 70-year history. With the society's help and...
Contributing Editor
|
11.21.2017
6:09am
The FDA issued updates regarding drugs that are currently in shortage. The list includes one tablet group discontinued by Mylan.
Contributing Editor
|
11.20.2017
9:48am
Oxford will supply Twist with its SnapFast technology platform to provide a broad range of application-specific expression vectors. which will be used to clone...
Contributing Editor
|
11.17.2017
5:27am
The aim is to make progress in elucidating the causes of disease, screening for drug leads, developing experimental drugs, preparing for clinical trials,...
Contributing Editor
|
11.16.2017
7:41am
UPDATED 11/15/17 ... Bleomycin Sulfate for Injection (Resolved). The FDA issued updates over the past week regarding drugs that are currently in shortage or...
Contributing Editor
|
11.14.2017
8:00am
Sanfilippo syndrome is a progressive disorder that primarily affects the brain and spinal cord. Features of the condition generally do not surface at birth,...
Contributing Editor
|
11.10.2017
8:00am